Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation.

PubWeight™: 3.17‹?› | Rank: Top 1%

🔗 View Article (PMC 2979326)

Published in Anesth Analg on September 01, 1985

Authors

Y G Kang, D J Martin, J Marquez, J H Lewis, F A Bontempo, B W Shaw, T E Starzl, P M Winter

Associated clinical trials:

Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant | NCT02239991

Articles citing this

Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation. Semin Liver Dis (1985) 2.16

The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation (1992) 1.83

Endotoxaemia, pulmonary complications, and thrombocytopenia in liver transplantation. Lancet (1989) 1.82

Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. Clin Transplant (1989) 1.74

Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation. Anesthesiology (1987) 1.39

Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. Scand J Trauma Resusc Emerg Med (2009) 1.38

Endotoxemia and human liver transplantation. Transplant Proc (1989) 1.28

Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography. J Thromb Haemost (2005) 1.19

New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17

Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography. Semin Thromb Hemost (2010) 1.13

Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology. Biophys J (1999) 1.12

The incidence and magnitude of fibrinolytic activation in trauma patients: a rebuttal. J Thromb Haemost (2013) 1.08

The role of hemostatic mechanisms in the development of thrombosis in Behcet's disease: an analysis by modified rotation thromboelastogram (ROTEM). Clin Rheumatol (2013) 1.08

Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation (1989) 1.06

Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med (2013) 0.99

Intraoperative blood transfusions in highly alloimmunized patients undergoing orthotopic liver transplantation. Transplantation (1989) 0.98

Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care (2006) 0.95

TEG® and ROTEM® in trauma: similar test but different results? World J Emerg Surg (2012) 0.95

Trauma-Induced Coagulopathy: An Institution's 35 Year Perspective on Practice and Research. Scand J Surg (2014) 0.93

Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants. Hepatology (1989) 0.92

Transfusion and coagulation management in liver transplantation. World J Gastroenterol (2014) 0.92

Thromboelastography in patients with acute ischemic stroke. Int J Stroke (2012) 0.91

A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Thromb J (2015) 0.90

Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application. Ann Surg (2004) 0.90

Prediction of neonatal sepsis by thromboelastography. Pediatr Surg Int (1997) 0.89

Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol Hepatol (N Y) (2012) 0.88

Critical care issues in adult liver transplantation. Indian J Crit Care Med (2009) 0.88

HLA alloimmunization and blood requirements in orthotopic liver transplantation. Transplant Proc (1989) 0.87

Liver transplantation without the use of blood products. Arch Surg (1994) 0.87

Thromboelastography of patients after fontan compared with healthy children. Pediatr Cardiol (2009) 0.87

Assays of different aspects of haemostasis - what do they measure? Thromb J (2015) 0.84

Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk. Thromb J (2015) 0.84

Coagulopathy after a liver resection: is it over diagnosed and over treated? HPB (Oxford) (2013) 0.84

Rotational thrombelastometry: a step forward to safer patient care? Crit Care (2014) 0.82

Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography. PLoS One (2015) 0.80

Tissue-type-plasminogen-activator-associated fibrinolysis in orthotopic liver transplantation. Transplant Proc (1989) 0.80

Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders. Drug Des Devel Ther (2010) 0.79

Evaluation of the utility of thromboelastography in a tertiary trauma care centre. ISRN Hematol (2014) 0.77

Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease. Visc Med (2016) 0.76

Cross-Sectional Guidelines for Therapy with Blood Components and Plasma Derivatives: Chapter 5 Human Albumin - Revised. Transfus Med Hemother (2016) 0.76

Application of basic and composite thrombelastography parameters in monitoring of the antithrombotic effect of the low molecular weight heparin dalteparin: an in vivo study. Thromb J (2009) 0.76

A systematic review on the rotational thrombelastometry (ROTEM®) values for the diagnosis of coagulopathy, prediction and guidance of blood transfusion and prediction of mortality in trauma patients. Scand J Trauma Resusc Emerg Med (2016) 0.76

Management of Trauma-Induced Coagulopathy with Thrombelastography. Crit Care Clin (2017) 0.75

Thromboelastographic Evaluation of Coagulation in Patients With Liver Disease. Ann Lab Med (2017) 0.75

Hyperfibrinolysis. J Clin Pathol (1996) 0.75

Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy. Curr Drug Targets (2016) 0.75

Flow cytometry and thromboelastography to assess platelet counts and coagulation in patients with haematological malignancies. Blood Transfus (2014) 0.75

Thromboelastography and peripartum coagulation profiles associated with caesarean section delivery. Obstet Med (2009) 0.75

Coagulopathy and transfusion therapy in pediatric liver transplantation. World J Gastroenterol (2016) 0.75

Reduced Transfusion During OLT by POC Coagulation Management and TEG Functional Fibrinogen: A Retrospective Observational Study. Transplant Direct (2015) 0.75

Thromboelastographic reference ranges for a cirrhotic patient population undergoing liver transplantation. World J Transplant (2016) 0.75

Thromboelastography in Dogs with Chronic Hepatopathies. J Vet Intern Med (2017) 0.75

Evaluation of hemostatic abnormalities in canine spirocercosis and its association with systemic inflammation. J Vet Intern Med (2013) 0.75

Thromboelastogram showing an undesirable effect of platelet transfusion on blood coagulability and fibrinolysis in a patient with aplastic anemia. J Anesth (1997) 0.75

Viscoelastic testing inside and beyond the operating room. J Thorac Dis (2017) 0.75

Articles cited by this

Evolution of liver transplantation. Hepatology (1982) 19.54

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A (1981) 3.88

On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost (1980) 3.44

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Changes in blood coagulation. Arch Surg (1966) 3.22

ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES. J Clin Invest (1964) 2.52

Coagulation during and after orthotopic transplantation of the human liver. Arch Surg (1969) 2.03

Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78

Changes in coagulation and fibrinolysis after orthotopic canine liver homotransplantation. J Lab Clin Med (1969) 1.63

Comparison of thrombelastography with common coagulation tests. Thromb Haemost (1981) 1.58

Study of clotting factors in liver homotransplantation. Am J Surg (1966) 1.35

Coagulation defects. JAMA (1961) 1.33

Bleeding and coagulation abnormalities in alcoholic cirrhotic liver disease. Alcohol Clin Exp Res (1982) 1.22

Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver. J Lab Clin Med (1974) 1.16

Liver transplantation in man--IV, Haemorrhage and thrombosis. Br Med J (1969) 1.14

Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease. J Clin Invest (1978) 1.04

Platelet dynamics in chronic liver disease with special reference to the role of the spleen. J Clin Pathol (1977) 1.03

A comparison of intraoperative measurements of coagulation. Anesth Analg (1974) 1.00

Proceedings: Hypercoagulability. Thrombelastographic monitoring during extensive hepatic surgery. Arch Surg (1974) 0.95

Electronic readout for three-channel thrombelastograph. J Med (1978) 0.89

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Xyloglucan endotransglycosylase, a new wall-loosening enzyme activity from plants. Biochem J (1992) 6.77

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections. J Infect Dis (1989) 6.49

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med (1988) 5.92

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIV. COMPARATIVE STUDIES ON THE NUTRITIVE VALUE OF ORALLY AND INTRAVENOUSLY ADMINISTERED HUMAN SERUM ALBUMIN IN MAN. J Clin Invest (1948) 5.08

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA (1994) 4.85

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Role of liver transplantation in cancer therapy. Ann Surg (1985) 4.08

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol (1997) 3.80

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

Hiccups: causes and cures. J Clin Gastroenterol (1985) 3.25

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15

The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation (1991) 3.14

A new Micromonospora-produced macrolide antibiotic, rosamicin. J Antibiot (Tokyo) (1972) 3.12

Fungal infections in liver transplant recipients. Transplantation (1985) 3.07

De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03

Experience with 150 liver resections. Ann Surg (1983) 3.01

A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Death after transplantation; an analysis of sixty cases. Am J Med (1967) 2.99

Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease. N Engl J Med (1992) 2.98

Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95

Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95

Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Heart-liver transplantation in a patient with familial hypercholesterolaemia. Lancet (1984) 2.91